How Tumors Block NK Cell Activation and How to Restore It
Author Information
Author(s): Wilson Erica B., El-Jawhari Jehan J., Neilson Abbie L., Hall Geoffrey D., Melcher Alan A., Meade Josephine L., Cook Graham P.
Primary Institution: Leeds Institute of Molecular Medicine, University of Leeds
Hypothesis
Can blocking TGF-β restore the activation of NK cells inhibited by tumors?
Conclusion
Blocking TGF-β can restore the effector function of NK cells that are inhibited by tumor cells.
Supporting Evidence
- TGF-β inhibits NK cell activation by reducing the expression of activation receptors.
- Blocking TGF-β can restore NK cell function in the presence of tumor cells.
- NK cells remain viable despite being inhibited by TGF-β in the tumor microenvironment.
- Chronic interactions between NK cells and tumor cells lead to local TGF-β mediated inhibition.
Takeaway
Cancer cells can trick our immune cells, called NK cells, into being less active. But if we block a certain signal from the cancer cells, we can help the NK cells fight back.
Methodology
The study involved co-culturing NK cells with tumor cells and analyzing the effects of TGF-β on NK cell activation and survival.
Limitations
The study primarily used in vitro models and may not fully represent in vivo conditions.
Participant Demographics
Patients with advanced ovarian cancer were involved in the study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website